ImpediMed Expanding Lymphedema Assessment Platform
The San Diego Business Journal is covering how ImpediMed is expanding early detection with a $15M growth capital facility—because every survivor should have access to proactive care.
We use cookies to make your visit to our website as pleasant as possible. If you continue to use the website, you agree to our privacy policy and to the use of cookies. More information about cookies and how ImpediMed uses them is available in our Cookie and Privacy Policy.
